Alterity Therapeutics Ltd.ASX: ATH

FDA Orphan Drug Designation for PBT2 for Huntington Disease

Mar 30, 2016 at 12:37 PM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment